Previous close | 42.80 |
Open | 42.83 |
Bid | 41.52 x 0 |
Ask | 44.07 x 0 |
Day's range | 42.49 - 42.83 |
52-week range | 37.95 - 56.49 |
Volume | |
Avg. volume | 294,002 |
Market cap | 9.664B |
Beta (5Y monthly) | 0.32 |
PE ratio (TTM) | 19.57 |
EPS (TTM) | 2.17 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HILDEN, Germany & GERMANTOWN, Md., May 19, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its recently launched, environmentally friendlier QIAwave nucleic-acid extraction kits have received the prestigious ACT Environmental Impact Factor Label from My Green Lab, a non-profit organization dedicated to advancing sustainability in scientific research.
Investors are optimistic about QIAGEN (QGEN), owing to strong international growth and bullish guidance.
The launch of QIAstat-Dx Rise and other advancements to the QIAstat-Dx portfolio are expected to strengthen QIAGEN's (QGEN) syndromic testing solutions.